A Blood-Based Cancer Test Gets Its First Results
A Blood-Based Cancer Test Gets Its First Results
Science, Spoken · SpokenLayer
June 5, 20184m 50s
Audio is streamed directly from the publisher (dovetail.prxu.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The bets on liquid biopsy keep getting bigger. Last month, Silicon Valley unicorn Grail Inc. raised a third round of financing to develop its blood-based tests for early cancer detection. That brings its total up to $1.5 billion since 2016, putting it among the top three most heavily funded private biotech companies in the US. While investors might be bullish on the risky venture, many oncologists have been more skeptical about how well Grail’s technique might work.
Learn about your ad choices: dovetail.prx.org/ad-choices